Donald Trump touted his “energy dominance” agenda, claiming American oil production is up 600,000 barrels per day and the US ...

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and ...

Louisiana Attorney General Liz Murrill will argue in federal court in Lafayette Tuesday for an injunction to stop the FDA's ...

Pfizer (PFE) stock is in focus as the FDA grants full approval for its colorectal cancer drug Braftovi, developed with Ono Pharmaceutical (OPHLF). Read more here.

The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of Ozempic will fall to $675 - around a third less than its current $1,027 ...

The CDC has assigned Mar. 18–19 as dates for the next meeting of its vaccine advisors after delaying an earlier meeting of the panel following a lawsuit. Read more here.

Using patent intelligence data from the FounderNest platform, Gonzalez highlights where small-molecule synthesis, formulation ...

Late-Stage Pipeline Advancements and Novel Therapies Position Sector for Accelerated Growth and Major Value CatalystsMarket News Updates News ...

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had ...

The biotech is developing a drug aimed at a protein called PACAP, which has emerged as a potentially new way to prevent the ...

New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for BEAM-304 Anticipated in 2026 Updated Phase 1/2 Data and Next ...